Having trouble accessing articles? Reset your cache.

Linaclotide: Completed Phase III enrollment

Ironwood completed enrollment of about 800 patients in each of two double-blind, placebo-controlled North American Phase III trials of linaclotide. One study is evaluating 266 µg oral

Read the full 272 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE